Meiragtx Holdings Plc (MGTX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
MeiraGTx Holdings plc has reached a significant milestone by earning $50 million from Janssen Pharmaceuticals, as part of their December 2023 agreement for botaretigene sparoparvovec, a gene therapy treatment for X-linked retinitis pigmentosa. This achievement underscores the company’s progress and potential in the field of medical biotechnology, marking a notable moment for investors watching the innovative therapy’s journey towards commercial success.
For further insights into MGTX stock, check out TipRanks’ Stock Analysis page.
